Frank Faris, MD
Gastroenterology · Las Vegas, NVNPI 1376644344
Payments from drug & device makers
Across 655 payments — averaging $21.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Johnson & Johnson$2K
- Intra-sana Laboratories$2K
- Takeda Pharmaceuticals U.S.A., Inc.$921
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$828
- Ferring Pharmaceuticals Inc.$474
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 162 | $4,000 |
| Johnson & Johnson(2 entities) | 107 | $2,365 |
| Intra-sana Laboratories | 117 | $2,074 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $921 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 56 | $828 |
| Ferring Pharmaceuticals Inc. | 27 | $474 |
| Braintree Laboratories, Inc. | 16 | $434 |
| Merck | 22 | $410 |
| Sanofi | 19 | $405 |
| Gilead | 11 | $370 |
| Ironwood Pharmaceuticals, Inc | 17 | $308 |
| Regeneron Healthcare Solutions, Inc. | 8 | $245 |
| Nestle Healthcare Nutrition Inc. | 11 | $218 |
| Pfizer | 10 | $187 |
| Enterra Medical, Inc. | 1 | $166 |
| QOL Medical, LLC | 1 | $161 |
| Bristol Myers Squibb | 5 | $115 |
| Intercept Pharmaceuticals, Inc. | 5 | $84 |
| Aimmune Therapeutics, Inc. | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
| UCB, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Ardelyx, Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Novo Nordisk | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Redhill Biopharma Inc. | 1 | $21 |
| Concordia Pharmaceuticals Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $18 |
| AstraZeneca | 1 | $14 |
How this compares
$14,269 in reported general payments places this provider in the 80th percentile of 103 gastroenterology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Las Vegas
- Christian StoneLas Vegas$3.7M
- Michael ZimmermanLas Vegas$717K
- James HanLas Vegas$47K
- Tousif PashaLas Vegas$44K
- Filippo CremoniniLas Vegas$36K
- Vijay JayaramanLas Vegas$28K
- Gary ChenLas Vegas$27K
- David ShihLas Vegas$26K
- Noel FajardoLas Vegas$22K
- Tarek AmmarLas Vegas$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.